Articles

The Evolution of the Safe Handling of Hazardous Chemotherapy Drugs

In 1979, Falck and colleagues described the presence of chemotherapy in the urine of nurses caring for patients who had received chemotherapy.1 The discovery that merely handling chemotherapy drugs can lead to absorption of the chemotherapy drugs has been key in the re-evaluation of safety in healthcare environments. In 2004, the National Institute for Occupational Safety and Health (NIOSH) alert noted that skin rashes, infertility, miscarriage, birth defects, and leukemia or other cancers may be associated with working with or near hazardous drugs.2

Read More ›

Advanced nurse practitioner Bridgett Harr, CPN, works at the Cleveland Clinic Foundation, and spoke about her work, and an award-winning study about clinic-based acute rehabilitation for patients led by advanced practice nurses. Read More ›

Women being treated for cancer appear to benefit from a psychological intervention aimed at counseling them on fertility preservation, according to a study reported by the National Comprehensive Cancer Network. Read More ›

The doctoral degree in nursing is earned as either a professional or a practice degree. Nurses with professional doctorates (PhDs) test and validate new knowledge; whereas, nurses with practice doctorates (DNPs) apply concepts into best practices in the clinical setting. Read More ›

The Cancer Support Community (CSC) has developed the Cancer Experience Registry, which is a unique resource that provides evidence-based data about the emotional, social, physical, and financial issues patients and caregivers face. Read More ›

We hope you enjoy this issue, and sincerely look forward to receiving your feedback. Read More ›

Noteworthy Numbers: Melanoma
In recognition of May as Melanoma/Skin Cancer Detection and Prevention Month, and May 27 as the American Cancer Society’s Don’t Fry Day, here are some details about a few types of skin cancer. Read More ›

  • FDA Approves First and Only Blood-Based Colorectal Cancer Screening Test
  • Imbruvica Now FDA Approved for First-Line Treatment of Patients with CLL
  • Gazyva Approved for the Treatment of Relapsed or Refractory Follicular Lymphoma
  • Ibrance Receives an Expanded Indication in Breast Cancer
  • Kyprolis Receives New Indication for Relapsed or Refractory Multiple Myeloma
  • Venclexta First BCL-2 Targeted Drug Approved for Patients with CLL plus 17p Deletion
Read More ›

Patients who undergo gastrectomy are at high risk for poor bone health and vitamin D deficiency and should be assessed and treated for this, according to researchers from Australia who described these issues at the 2016 Gastrointestinal Cancers Symposium. Read More ›

Belgian researchers have developed an interactive cell phone–based tool that patients on oral chemotherapy can use daily to report adherence, adverse events, and other concerns. Read More ›

Page 197 of 376


Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: